Loading...
OTC Markets
Totals
Securities
12,253
Dollar Vol
$2.5B
Share Vol
5.2B
Trades
355,769

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

HMNU
Human Unitec International, Inc.

Common Stock
OTC Disclosure & News Service
HUMAN UNITEC INTERNATIONAL INC ANNOUNCES THREE STRATEGIC MARKETING AGREEMENTS FOR ITS HMNU-MSK KINESIS MEDICAL EQUIPMENT WITH INITIAL MINIMUM ANNUAL ORDERS EXCEEDINGTHIRTY MILLION USD.


Human Unitec International, Inc., (OTC Pink: HMNU) ("HMNU"), is a Project Finance, Management & Development Company for Sustainability, Medical, Wellness, and Green Energy, announces three strategic marketing agreements for its HMNU-MSK Kinesis Medical Equipment.  



On May 24, 2022, after the result of four (4) years of coorboaration, testing and equiment design, HMNU signed an agreement with Compagnia del Cavallo s.r.l.  and its President Sergio Tramontano as the exclusive agent for Europe of the MSK Kinesis equipment and treatment protocols for vetinary medicine, 

On May 24, 2022, HMNU signed an agreement with Prof. Dr. Francesco Braconaro, Dr Orthopedic, Medical Director Maugeri Group-ICS, Milano, Italy;  President Medical Board HMNU MEDICAL and Physician for National Team of Italy to market the sports medicine equipment from HMNU-MSK Kinesis. 

On May 24, 2022,  HMNU Signed an agreement with Dr. Amir Ghazy Mir Saeid, Milano

Physiotherapy Doctor, Specialist in sport medecine and traumatologie. Dr. Saied has been appointed as  the exclusive Italian Representative for HMNU Medical sport departments in Italy. 

The three entities have agreed to an annual sales of 900 HMNU – MSK Kinesis medical machines at a minimum cost of 39,000 USD each for a minimum annual revenue in excess of Thirty Milion USD. 

These agreements were finalized with the Human Unitec launch of its new generation of its medical and wellness equipment designed for use in the European market. The design of this new line is the result of our MSK Kinesis team’s years of study and from the successful treatments on patients for treatment of Parkinson diseases, prevention of blood clots and thrombosis dysfunctions. The equipment is made with  ABS  and Environmental Protection materials. The HMNU/MSK equipment has been EU and CE tested and approved for wellness, medical, sports and veterinary use. 


About Human Unitec International, Inc.,

Human Unitec International, Inc., is a Project Finance, Management & Development Company engaged in Medical, Wellness, and Green Energy. We are listed on the US OTC Market. (OTC-HMNU).

Human Unitec International, Inc.
551 Warren street, 12075 Hudson, NY, USA
Contact: Telephone (917)8219585
Email: hmnuusa@gmail.com
https://twitter.com/HMNU_1
www.hmnuusa.com 



Forward-looking statements

This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Human Unitec International Inc., (HMNU),  a startup company, and certain of the plans and objectives of  HMNU with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

These factors include, but are not limited to, domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where HMNU operates, industry consolidation and competition. As a result, HMNU actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements.

Page 1 of
Loading PDF...
Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.